Ultramist therapy uses ultrasound energy to stimulate the wound bed in order to accelerate healing. The ultrasound wave is produced by the device and then passed through a mist until it reaches the wound bed. The energy is then absorbed by the wound bed. The oscillations of the ultrasound wave cause the tissues within the wound bed to stretch and compress at a microscopic level. This stimulation brings fresh blood and nutrients to the cells within the wound and promotes genesis of new tissue. Think of it as a microscopic massage for your wound.
High levels of bacteria in wounds delay healing. Mechanical stress caused by low frequency and noncontact ultrasound acoustic wave therapy result in bacterial cell death and reduction of bacterial count, even in highly colonized stage 3 pressure ulcers.
Bacterial biofilm is a structured community of bacteria tightly enclosed within a self-produced exopolymeric matrix, and its presence is a significant barrier to wound or tissue healing. Since bacterial biofilm is metabolically inactive, it is extremely hard to disrupt with topical/systemic antibiotics, antimicrobials, and/or antiseptics. Ultrasonic Mist Debridement has been proven to remove biofilm from the wound bed creating a favorable healing environment.
Initial injury triggers an inflammatory response within a wound. Controlled inflammation is beneficial, but sustained inflammation can lead to stalled healing. Cellular balance is restored by reducing sustained levels of inflammation, allowing wound healing to progress. A Boston University Study demonstrated that Ultrasound Mist Debridement effectively reduced inflammatory markers within the wound and reduced total inflammation.
Adequate perfusion and vasodilation are required to promote wound and tissue healing. In a Mayo Clinic study, ultrasound mist debridement treatments improved perfusion to the wound bed that promotes wound healing. Blood flow is especially crucial in deep tissue pressure injuries (DTPI). A retrospective study of DPTIs found 80% did not progress beyond stage 2 with the UltraMIST System combined with standard of care (SOC) versus 22% with SOC alone.
New blood vessel formation is an essential component of wound healing as new capillary development and growth are needed to repair damaged tissue. In a 2004 study, ultrasound debridement mist therapy accelerated angiogenesis in a diabetic mouse model. In another study, it was associated with spikes in vascular endothelial growth factor (VEGF) in nonhealing diabetic foot ulcers. The ultrasound mist debridement group achieved an 86% wound area reduction versus 39% for SOC group.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.